Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

John W EikelboomSanjit S JollyEmilie P Belley-CoteRichard P WhitlockSumathy RangarajanLizhen XuLaura HeenanShrikant I BangdiwalaMaria Luz DiazRafael DiazAfzalhussein YusufaliSanjib Kumar SharmaWadea M TarhuniMohamed HassanyAlvaro AvezumWilliam HarperSean WassermanAysha AlmasOxana DrapkinaFELIX GALLEGOS, CAMILO EDGAR VINICIOCAMILO EDGAR VINICIOFELIX GALLEGOSRenato D LopesOtavio BerwangerPatricio Lopez-JaramilloSonia S AnandJackie BoschShurjeel ChoudhriMichael E FarkouhMark LoebSalim Yusuf2024-11-062024-11-062022-1210.1016/S2213-2600(22)00298-3https://cris.ute.edu.ec/handle/123456789/454Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trialjournal-article